Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients

Sponsor
M.D. Anderson Cancer Center
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT04188418
This phase II trial studies fentanyl buccal tablet or morphine to see how well it works compared to a placebo in controlling shortness of breath during or after physical activity in cancer patients. Fentanyl sublingual tablet and morphine are opioids normally used to control pain that may also help to prevent or control shortness of breath during or after physical activity in cancer patients.
Intervention
Placebo Administration, Physical Performance Testing, Fentanyl Citrate Buccal Tablet, Quality-of-Life Assessment, Questionnaire Administration, Morphine
Condition
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Investigators
David Hui

See list of participating sites